Quick Takeaways
- RIGL - RIGEL PHARMACEUTICALS INC has 18 insiders with reported activity on this page.
- Net insider value flow over the last year: -$145,440.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 18 Insiders of RIGEL PHARMACEUTICALS INC
- Symbol
- RIGL on Nasdaq
- Location
- South San Francisco, CA
What Changed
- Buy value: ; sell value: $145,440.
- Net share flow: -4,000.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$145,440.
Buys
$0
Shares: 0
Insiders: 0
Sells
$145,440
Shares: 4,000
Insiders: 1
Net
-$145,440
Shares: -4,000
Insiders: -1
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 4,000 | $0 | $145,440 | -$145,440 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
RIGEL PHARMACEUTICALS INC executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Raul R. Rodriguez | CEO, President, Director | $10,569,997 | Mixed | 17 Feb 2026 | ||
| Dean L. Schorno | EVP & Chief Financial Officer | $2,861,110 | Mixed | 17 Feb 2026 | ||
| David A. Santos | EVP, Chief Commercial Officer | $2,356,367 | Mixed | 17 Feb 2026 | ||
| Raymond J. Furey | EVP, GC, CCO & Corp Sec | $1,941,951 | Mixed | 17 Feb 2026 | ||
| Lisa Rojkjaer | EVP, Chief Medical Officer | $1,306,290 | Mixed | 17 Feb 2026 | ||
| Walter H. Moos | Director | $462,571 | -$145,440 | -24% | Filing P/S | 20 Feb 2026 |
| Anthony Gregg Lapointe | Director | $238,250 | Mixed | 23 May 2025 | ||
| Jane Wasman | Director | $238,250 | Mixed | 23 May 2025 | ||
| Alison L. Hannah | Director | $202,512 | Mixed | 23 May 2025 | ||
| Kamil Ali-Jackson | Director | $178,687 | Mixed | 23 May 2025 | ||
| Gary A. Lyons | Director | $131,250 | Mixed | 26 May 2023 | ||
| Wolfgang Dummer | Evp & Cmo | $126,803 | Mixed | 02 Feb 2023 | ||
| Brian L. Kotzin | Director | $114,000 | Mixed | 25 May 2024 | ||
| Bradford S. Goodwin | Director | $61,250 | Mixed | 19 May 2021 | ||
| Keith Katkin | Director | $43,750 | Mixed | 19 May 2021 | ||
| Mark W. Frohlich | Director | $23,825 | Mixed | 23 May 2025 | ||
| Michael Patrick Miller | Director | $8,009 | Mixed | 01 Feb 2026 | ||
| Dolly Vance | EVP Corp. Affairs, G.C., Sect. | Mixed | 14 Sep 2022 |
Top shareholders of RIGEL PHARMACEUTICALS INC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.7%
from 13D/G
|
1,667,726
mixed-class rows
|
$71,292,416 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
13D/G
|
Company · STATE STREET CORPORATION |
6%
from 13D/G
|
1,091,223
|
$46,737,081 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
—
mixed-class rows
|
1,063,118
mixed-class rows
|
$44,574,843 | — | 31 Dec 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
13D/G
|
Company |
4%
from 13D/G
|
836,000
|
$35,805,880 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
3.7%
|
671,878
|
$28,776,535 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
3.4%
|
613,600
|
$26,280,489 | — | 31 Dec 2025 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
3%
|
544,282
|
$23,312,000 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3%
|
539,009
|
$23,085,755 | — | 31 Dec 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
2.7%
|
493,604
|
$21,132,000 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.4%
|
431,460
|
$18,479,432 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
mixed-class rows
|
445,729
mixed-class rows
|
$18,264,128 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2.3%
|
424,316
|
$18,173,454 | — | 31 Dec 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
2.3%
|
413,659
|
$17,717,015 | — | 31 Dec 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1.6%
|
300,034
|
$12,850,456 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
1.6%
|
288,269
|
$12,346,561 | — | 31 Dec 2025 | |
| Soleus Capital Master Fund, L.P. |
13D/G
|
— |
3.7%
|
658,145
|
$12,327,056 | -$8,850,562 | 30 Jun 2025 | |
| Hillsdale Investment Management Inc. |
13F
|
Company |
1.6%
|
282,584
|
$12,103,074 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
—
mixed-class rows
|
298,767
mixed-class rows
|
$11,909,155 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.5%
|
276,812
|
$11,855,857 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.5%
|
271,228
|
$11,616,695 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
1.4%
|
258,893
|
$11,088,387 | — | 31 Dec 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
1.4%
|
254,492
|
$10,899,892 | — | 31 Dec 2025 | |
| Raul R. Rodriguez |
3/4/5
|
CEO, President, Director |
1.6%
|
282,017
|
$10,569,997 | — | 17 Feb 2026 | |
| CM Management, LLC |
13F
|
Company |
1.2%
|
225,000
|
$9,636,750 | — | 31 Dec 2025 | |
| GLOBEFLEX CAPITAL L P |
13F
|
Company |
1.2%
|
217,839
|
$9,330,044 | — | 31 Dec 2025 | |
| Trexquant Investment LP |
13F
|
Company |
1.1%
|
197,148
|
$8,443,849 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1%
|
185,419
|
$7,941,496 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
13D/G
|
Company |
0.7%
from 13D/G
|
166,489
|
$7,130,765 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.82%
|
148,636
|
$6,366,080 | — | 31 Dec 2025 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.74%
|
135,428
|
$5,800,381 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.71%
|
129,022
|
$5,526,011 | — | 31 Dec 2025 | |
| ZACKS INVESTMENT MANAGEMENT |
13F
|
Company |
0.65%
|
119,088
|
$5,100,534 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
mixed-class rows
|
116,969
mixed-class rows
|
$5,009,122 | — | 31 Dec 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.6%
|
109,736
|
$4,699,993 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.6%
|
108,266
|
$4,637,037 | — | 31 Dec 2025 | |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC |
13F
|
Company |
0.59%
|
107,989
|
$4,625,169 | — | 31 Dec 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.59%
|
107,969
|
$4,624,312 | — | 31 Dec 2025 | |
| RITHOLTZ WEALTH MANAGEMENT |
13F
|
Company |
0.44%
|
80,593
|
$3,451,798 | — | 31 Dec 2025 | |
| Empire Financial Management Company, LLC |
13F
|
Company |
0.42%
|
76,445
|
$3,274,139 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.41%
|
75,359
|
$3,227,625 | — | 31 Dec 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.41%
|
73,850
|
$3,162,994 | — | 31 Dec 2025 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.39%
|
71,570
|
$3,065,343 | — | 31 Dec 2025 | |
| Opaleye Management Inc. |
13F
|
Company |
0.38%
|
70,000
|
$2,998,100 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
0.37%
|
67,838
|
$2,905,504 | — | 31 Dec 2025 | |
| Dean L. Schorno |
3/4/5
|
EVP & Chief Financial Officer |
—
mixed-class rows
|
87,169
mixed-class rows
|
$2,861,110 | — | 17 Feb 2026 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.36%
|
65,504
|
$2,805,536 | — | 31 Dec 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.36%
|
64,825
|
$2,776,454 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.34%
|
61,999
|
$2,655,417 | — | 31 Dec 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.34%
|
61,042
|
$2,614,429 | — | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.31%
|
57,001
|
$2,441,354 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for RIGEL PHARMACEUTICALS INC
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Walter H. Moos | RIGL | Common Stock | Sale | -23.9% | $145,440 | $36.36 | -4,000 | 12,722 | 20 Feb 2026 | Direct |
| Walter H. Moos | RIGL | Common Stock | Options Exercise | 31.4% | 4,000 | 16,722 | 20 Feb 2026 | Direct | ||
| Walter H. Moos | RIGL | Stock Option (right to buy) | Options Exercise | -100% | -4,000 | 0 | 20 Feb 2026 | Direct | ||
| Raymond J. Furey | RIGL | Common Stock | Award | 60.3% | 19,497 | 51,813 | 17 Feb 2026 | Direct | ||
| Raul R. Rodriguez | RIGL | Common Stock | Award | 23.6% | 53,915 | 282,017 | 17 Feb 2026 | Direct | ||
| Lisa Rojkjaer | RIGL | Common Stock | Award | 118.4% | 18,894 | 34,853 | 17 Feb 2026 | Direct | ||
| David A. Santos | RIGL | Common Stock | Award | 44.7% | 19,430 | 62,870 | 17 Feb 2026 | Direct | ||
| Dean L. Schorno | RIGL | Common Stock | Award | 37% | 20,636 | 76,337 | 17 Feb 2026 | Direct | ||
| Dean L. Schorno | RIGL | Common Stock | Tax liability | -5.99% | -3,546 | 55,701 | 10 Feb 2026 | Direct | ||
| Raymond J. Furey | RIGL | Common Stock | Tax liability | -9.89% | -3,546 | 32,316 | 10 Feb 2026 | Direct | ||
| David A. Santos | RIGL | Common Stock | Tax liability | -7.55% | -3,546 | 43,440 | 10 Feb 2026 | Direct | ||
| Raul R. Rodriguez | RIGL | Common Stock | Tax liability | -3.23% | -7,607 | 228,102 | 10 Feb 2026 | Direct | ||
| Lisa Rojkjaer | RIGL | Common Stock | Tax liability | -19.1% | -3,758 | 15,959 | 10 Feb 2026 | Direct | ||
| David A. Santos | RIGL | Common Stock | Tax liability | -10.8% | -5,718 | 46,986 | 02 Feb 2026 | Direct | ||
| Dean L. Schorno | RIGL | Common Stock | Tax liability | -8.48% | -5,488 | 59,247 | 02 Feb 2026 | Direct | ||
| Raymond J. Furey | RIGL | Common Stock | Tax liability | -9.96% | -3,968 | 35,862 | 02 Feb 2026 | Direct | ||
| Raul R. Rodriguez | RIGL | Common Stock | Tax liability | -5.65% | -14,110 | 235,709 | 02 Feb 2026 | Direct | ||
| Michael Patrick Miller | RIGL | Stock Option (right to buy) | Award | 12,000 | 12,000 | 01 Feb 2026 | Direct | |||
| Raul R. Rodriguez | RIGL | Common Stock | Tax liability | -22.4% | -70,635 | 245,243 | 26 Jan 2026 | Direct | ||
| Raul R. Rodriguez | RIGL | Common Stock | Options Exercise | 39% | 80,000 | 285,243 | 26 Jan 2026 | Direct | ||
| Raul R. Rodriguez | RIGL | Employee Stock Option (right to buy) | Options Exercise | -100% | -80,000 | 0 | 26 Jan 2026 | Direct | ||
| Dean L. Schorno | RIGL | Common Stock | Options Exercise | 11.3% | 6,500 | 64,235 | 22 Dec 2025 | Direct | ||
| Dean L. Schorno | RIGL | Employee Stock Option (right to buy) | Options Exercise | -37.5% | -6,500 | 10,832 | 22 Dec 2025 | Direct | ||
| Dean L. Schorno | RIGL | Employee Stock Option (right to buy) | Award | 7,394 | 7,394 | 15 Sep 2025 | Direct | |||
| David A. Santos | RIGL | Employee Stock Option (right to buy) | Award | 7,394 | 7,394 | 15 Sep 2025 | Direct | |||
| Lisa Rojkjaer | RIGL | Employee Stock Option (right to buy) | Award | 7,394 | 7,394 | 15 Sep 2025 | Direct | |||
| Raymond J. Furey | RIGL | Employee Stock Option (right to buy) | Award | 7,394 | 7,394 | 15 Sep 2025 | Direct | |||
| Raul R. Rodriguez | RIGL | Employee Stock Option (right to buy) | Award | 31,700 | 31,700 | 15 Sep 2025 | Direct | |||
| Jane Wasman | RIGL | Common Stock | Award | 25% | 2,500 | 12,500 | 23 May 2025 | Direct | ||
| Jane Wasman | RIGL | Stock Option (Right to Buy) | Award | 3,000 | 3,000 | 23 May 2025 | Direct | |||
| Kamil Ali-Jackson | RIGL | Common Stock | Award | 36.4% | 2,500 | 9,375 | 23 May 2025 | Direct | ||
| Kamil Ali-Jackson | RIGL | Stock Option (Right to Buy) | Award | 3,000 | 3,000 | 23 May 2025 | Direct | |||
| Walter H. Moos | RIGL | Common Stock | Award | 24.5% | 2,500 | 12,722 | 23 May 2025 | Direct | ||
| Walter H. Moos | RIGL | Stock Option (Right to Buy) | Award | 3,000 | 3,000 | 23 May 2025 | Direct | |||
| Anthony Gregg Lapointe | RIGL | Common Stock | Award | 25% | 2,500 | 12,500 | 23 May 2025 | Direct | ||
| Anthony Gregg Lapointe | RIGL | Stock Option (Right to Buy) | Award | 3,000 | 3,000 | 23 May 2025 | Direct | |||
| Alison L. Hannah | RIGL | Common Stock | Award | 30.8% | 2,500 | 10,625 | 23 May 2025 | Direct | ||
| Alison L. Hannah | RIGL | Stock Option (Right to Buy) | Award | 3,000 | 3,000 | 23 May 2025 | Direct | |||
| Mark W. Frohlich | RIGL | Common Stock | Award | 1,250 | 1,250 | 23 May 2025 | Direct | |||
| Mark W. Frohlich | RIGL | Stock Option (Right to Buy) | Award | 1,500 | 1,500 | 23 May 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.